<DOC>
	<DOCNO>NCT02138864</DOCNO>
	<brief_summary>The study purpose determine clinical value 18F-FP- ( + ) -DTBZ diagnosis Parkinsonism patient carbon monoxide intoxication , regional distribution correlation clinical parameter . This study expect completed period 3 year .</brief_summary>
	<brief_title>Targeting Monoaminergic Neuronal Networks Parkinsonian Patients After Carbon Monoxide Intoxication</brief_title>
	<detailed_description>With urbanization Taiwanese society , increase number people commit suicide charcoal burning , make carbon monoxide ( CO ) encephalopathy new pandemic phenomenon . In CO related parkinsonism , clinical feature include gait disturbance , mask face , rigidities small step . From literature search , CO relate parkinsonism relate white matter damage decline dopamine innervation . From previous research result , CO relate neuronal damage would start reversible progressive white matter demyelination . For patient , axonopathy gray matter atrophy develop become irreversible . The neuronal network determine development Parkinsonism require establish . In term neurotransmitter , clinical data Parkinsonism come study idiopathic Parkinson 's disease data CO relate Parkinsonism limit case report . From neuropathology study idiopathic Parkinson 's disease , dopamine deficit decrease monoamine transporter observe well development clinical feature . Although linkage CO relate Parkinsonism dopamine deficit , patient CO intoxication poor response levodopa . The observation suggest critical network neurotransmitter still well understood . 18F-FP- ( + ) -DTBZ newly develop nuclear medicine tracer monoamine transporter . The study purpose determine clinical value 18F-FP- ( + ) -DTBZ diagnosis Parkinsonism patient carbon monoxide intoxication , regional distribution correlation clinical parameter . This three-year prospective research . For patient , PET arrange twice , interval 18 month . The regional distribuation 18F-FP- ( + ) -DTBZ relation Parkinsonism severity regional reduction pattern longitudially assess order understand regional neurotoxicity functional progression .</detailed_description>
	<mesh_term>Parkinsonian Disorders</mesh_term>
	<mesh_term>Carbon Monoxide Poisoning</mesh_term>
	<mesh_term>Carbon Monoxide</mesh_term>
	<mesh_term>Tetrabenazine</mesh_term>
	<criteria>Inclusion criterion 1 . Male female age 20 year 65 year . 2 . Patients group fulfil diagnostic criterion carbon monoxide intoxication 3 . Patients provide write informed consent prior study entry . If patient incapable informed consent , caregiver may consent behalf patient ( patient must still confirm consent ) Exclusion criterion 1 . History developmental disorder , agitate mood confused state prevent either neuropsychiatric interview neuroimaging . 2 . Unable stay still PET scanner 30 minute . 3 . History presence QTc prolongation . ( &gt; 500msec ) 4 . Pregnancy breast feeding .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>carbon monoxide intoxication</keyword>
	<keyword>Parkinsonism</keyword>
	<keyword>18F-DTBZ AV-133</keyword>
</DOC>